AXL and glioma: Through competitively binding mR-33a-5P, miR-33b-5P, miR-1-3P, miR-206 and miR-613, ANCR increased AXL expression and activated PI3K/Akt/NF-κB signaling pathway that caused cisplatin resistance in glioma cells [14].